TargetRNA

Joint TargetRNA, Fragment Screen and IMPULSE Winter school

The PhD Winter Training School “Emerging Topics in Early-Stage Drug Discovery” brings together researchers from the Target RNA, Fragment Screen and IMPULSE networks for a week of interactive lectures, hands-on computational sessions, and networking activities.

The PhD Winter Training School “Emerging Topics in Early-Stage Drug Discovery” brings together researchers from the Target RNA and IMPULSE networks for a week of interactive lectures, hands-on computational sessions, and networking activities. The school will host around 30 PhD students and early-career scientists eager to deepen their understanding of how RNA can be explored and used as a therapeutic target.

Joint TargetRNA, Fragment Screen and IMPULSE Winter school on Emerging Topics in Early-Stage Drug Discovery– happening now in Madrid 26-30 January 2026.

The school will host around 30 PhD students and early-career scientists eager to deepen their understanding of how RNA can be explored and used as a therapeutic target.
Do you know a PhD, Postdoc or junior researcher that would be interested? Please spread the word!

The PhD Winter Training School “Emerging Topics in Early-Stage Drug Discovery” brings together researchers from the Target RNA and IMPULSE networks for a week of interactive lectures, hands-on computational sessions, and networking activities.

Nicolò will soon begin his planned secondment at the Institute for Technical Microbiology in Mannheim, focusing on in vitro transcription as well as the expression and purification of bacterial RNases. Best of luck, Nicolò!

Nicolò Mercorelli is a PhD student at the Technical University of Denmark in Copenhagen, where he is working under the supervision of Mads Clausen on the discovery of bacterial endoribonuclease recruiters (RIBOTACs).

Sviatlana has recently completed her secondment at Uppsala University, where she gained hands-on experience in vitro transcription.

Meet Sviatlana Kashyrskaya. She is based in Switzerland, at the University of Basel, where she works on NMR fragment screening to identify ligands that can interact with the 5′ untranslated region of ompA of Acinetobacter baumannii.

Curious about our progress? Stay tuned for our upcoming posts!

At the same time, these compounds offer the potential to selectively reshape the human gut microbiome without promoting resistance, an area with vast implications for medicine. By uniting leading scientists from 13 academic and 4 industry partners, we aim to redefine medicine through RNA.

Greetings from the TargetRNA consortium! This Marie Skłodowska-Curie Actions (MSCA) doctoral network brings together 16 PhD candidates from 9 countries across disciplines to address the global problem of antibiotic-resistant bacteria by developing antimicrobial compounds targeting bacterial RNA.

Kick-off for TargetRNA May 26th marked the kick-off for the doctoral network, gathering Ph.D. candidates from all over the world.

www.uib.no/en/med/17838...

We are looking for a PhD candidate to fill the last open position in the TargetRNA network. This position is about hit discovery and structural studies of riboswitch-ligand complexes using NMR and X-ray crystallography.
More information can be found here: efzu.fa.em2.oraclecloud.com/hcmUI/Candid...